ORPHA:281127
Acral self-healing collodion baby
Also known as: Acral SHCB
Clinical definition (Orphanet)
A variant of self-healing collodion baby (SHCB) characterized by the presence at birth of a collodion membrane only at the extremities.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Is anyone studying this?
17
17 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.
17 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).
11 in the last 10 years · high confidence · 32th percentile (publications denominator)
Is a treatment being tested?
0
trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 26 July 2026
No matched interventional trials. This is true for 59.2% of diseases in the trials denominator (151 of 255). Here are the researchers publishing on it.
high confidence · 29.6th percentile (trials denominator)
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Who's working on it?
114
Distinct author names in 17 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Rodríguez-Pazos L3 papers · 2020
Servicio de Dermatología del Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Papers in Europe PMC - 02Vega A3 papers · 2020
Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain. ana.vega@usc.es.
Papers in Europe PMC - 03Cutrone M2 papers · 2022
Pediatric Dermatology Outpatient Service, Angel Hospital, Mestre, Venice, Italy.
Papers in Europe PMC - 04Fachal L2 papers · 2020
Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.
Papers in Europe PMC - 05Ginarte M2 papers · 2019
Servicio de Dermatología del Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Papers in Europe PMC - 06Abdelhak S1 paper · 2024
Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, Tunis, Tunisia.
Papers in Europe PMC - 07Abdessalem G1 paper · 2024
Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, Tunis, Tunisia.
Papers in Europe PMC - 08Ács N1 paper · 2021
Department of Obstetrics and Gynaecology, Semmelweis University, 1082 Budapest, Hungary.
Papers in Europe PMC - 09
- 10Ahvazi B1 paper · 2009Papers in Europe PMC
Recruiting interventional trials
Trials testing a treatment from the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it above — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.
"Acral self-healing collodion baby" OR "Acral SHCB"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Acral self-healing collodion baby" OR "Acral SHCB"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Cross-references (from Mondo): UMLS:C4305324
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus